The Arrowhead 5th annual Translational Microbiome Conference is happening in Boston (USA), and Microbiome Insights will be there! The conference, which runs April 17th-18th, will provide education and discussion around commercialization of microbiome-based diagnostics, therapeutics, and adjunct therapies — as well as direct-to-consumer services and products.
Don’t miss this discussion on April 17th at 11:30 am moderated by Edward Burd, Ph.D., Head of Regulatory Affairs at Rebiotix:
Enhancing the Power of the Microbiome Through Partnership
Partnership in any business is a crucial component to success. In the growing arena of microbiome therapeutics, partnerships between scientific, clinical, governmental and corporate teams lend credibility, flexibility and speed to the development of novel technologies. Join in the discussion about how partnerships can accelerate the microbiome field and push the boundaries of innovation to help a broader class of patients. Microbiome Insights CEO & co-founder Malcolm Kendall will participate as a panelist in this session.
